BVS vs. NUTX
BVS (Bioventus Inc.) and NUTX (Nutex Health Inc) are both stocks. Both are in the Healthcare sector — BVS in Medical Devices, NUTX in Health Information Services. Over the past 3 years, BVS returned 42.42%/yr vs 25.11%/yr for NUTX. At a 0.10 correlation, their price movements are largely independent.
Performance
BVS vs. NUTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BVS achieves a 14.92% return, which is significantly higher than NUTX's -19.31% return.
BVS
- 1D
- 5.43%
- 1M
- -15.93%
- YTD
- 14.92%
- 6M
- 12.95%
- 1Y
- 28.38%
- 3Y*
- 42.42%
- 5Y*
- -13.88%
- 10Y*
- —
NUTX
- 1D
- 6.24%
- 1M
- -9.74%
- YTD
- -19.31%
- 6M
- 0.82%
- 1Y
- -10.33%
- 3Y*
- 25.11%
- 5Y*
- —
- 10Y*
- —
BVS vs. NUTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
BVS Bioventus Inc. | 14.92% | -29.14% | 99.24% | 101.92% | -80.36% |
NUTX Nutex Health Inc | -19.31% | 419.47% | 17.37% | -90.53% | -95.25% |
Correlation
The correlation between BVS and NUTX is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Apr 5, 2022 | 0.10 |
Fundamentals
BVS:
$0.41
NUTX:
$19.08
BVS:
20.74
NUTX:
6.96
BVS:
0.17
NUTX:
0.06
BVS:
1.02
NUTX:
0.76
BVS:
$576.30M
NUTX:
$879.95M
BVS:
$390.14M
NUTX:
$417.67M
BVS:
$98.72M
NUTX:
$275.94M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BVS vs. NUTX — Risk / Return Rank
BVS
NUTX
BVS vs. NUTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bioventus Inc. (BVS) and Nutex Health Inc (NUTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BVS | NUTX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.56 | -0.11 | +0.67 |
Sortino ratioReturn per unit of downside risk | 1.20 | 0.52 | +0.68 |
Omega ratioGain probability vs. loss probability | 1.15 | 1.06 | +0.08 |
Calmar ratioReturn relative to maximum drawdown | 1.04 | -0.19 | +1.23 |
Martin ratioReturn relative to average drawdown | 3.80 | -0.34 | +4.13 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BVS | NUTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.56 | -0.11 | +0.67 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.17 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.18 | -0.45 | +0.27 |
Drawdowns
BVS vs. NUTX - Drawdown Comparison
The maximum BVS drawdown since its inception was -95.18%, roughly equal to the maximum NUTX drawdown of -99.93%. Use the drawdown chart below to compare losses from any high point for BVS and NUTX.
Loading charts...
Drawdown Indicators
| BVS | NUTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.18% | -99.93% | +4.75% |
Max Drawdown (1Y)Largest decline over 1 year | -27.51% | -54.32% | +26.81% |
Max Drawdown (3Y)Largest decline over 3 years | -55.22% | -94.36% | +39.14% |
Max Drawdown (5Y)Largest decline over 5 years | -95.07% | — | — |
Current DrawdownCurrent decline from peak | -55.49% | -97.79% | +42.30% |
Average DrawdownAverage peak-to-trough decline | -56.39% | -97.27% | +40.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.50% | 32.67% | -25.17% |
Volatility
BVS vs. NUTX - Volatility Comparison
The current volatility for Bioventus Inc. (BVS) is 19.59%, while Nutex Health Inc (NUTX) has a volatility of 26.07%. This indicates that BVS experiences smaller price fluctuations and is considered to be less risky than NUTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BVS | NUTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.59% | 26.07% | -6.48% |
Volatility (6M)Calculated over the trailing 6-month period | 32.94% | 67.36% | -34.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 50.58% | 95.95% | -45.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 81.05% | 133.33% | -52.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 80.08% | 133.33% | -53.25% |
Dividends
BVS vs. NUTX - Dividend Comparison
Neither BVS nor NUTX has paid dividends to shareholders.
Financials
BVS vs. NUTX - Financials Comparison
This section allows you to compare key financial metrics between Bioventus Inc. and Nutex Health Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BVS vs. NUTX - Profitability Comparison
BVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported a gross profit of 90.77M and revenue of 132.09M. Therefore, the gross margin over that period was 68.7%.
NUTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nutex Health Inc reported a gross profit of 91.73M and revenue of 216.49M. Therefore, the gross margin over that period was 42.4%.
BVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported an operating income of 8.42M and revenue of 132.09M, resulting in an operating margin of 6.4%.
NUTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nutex Health Inc reported an operating income of 81.27M and revenue of 216.49M, resulting in an operating margin of 37.5%.
BVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported a net income of 3.11M and revenue of 132.09M, resulting in a net margin of 2.4%.
NUTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nutex Health Inc reported a net income of 46.81M and revenue of 216.49M, resulting in a net margin of 21.6%.
Frequently Asked Questions
BVS and NUTX have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NUTX has higher volatility (26.07%) compared to BVS (19.59%). In terms of maximum drawdown, BVS dropped -95.18% vs NUTX's -99.93%.
BVS currently has the higher Sharpe Ratio (0.56 vs -0.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BVS and NUTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer